Janney Montgomery Scott
BEAM icon

Janney Montgomery Scott’s Beam Therapeutics BEAM Stock Holding History

Janney Montgomery Scott’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,308
Closed -$396K – 2565
2022
Q3 		$396K Sell
8,308
-4,406
-35% -$251K ﹤0.01% 1842
2022
Q2 		$514K Buy
12,714
+668
+6% +$26.6K ﹤0.01% 1605
2022
Q1 		$690K Buy
12,046
+8,340
+225% +$547K ﹤0.01% 1451
2021
Q4 		$295K Sell
3,706
-2,885
-44% -$247K ﹤0.01% 2007
2021
Q3 		$573K Buy
+6,591
New +$662K ﹤0.01% 1573

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Janney Montgomery Scott's BEAM Position: Q4 2022 in Review

Janney Montgomery Scott sold out of Beam Therapeutics (BEAM) in Q4 2022, closing a stake of 8,308 shares — an estimated $396K sold.

Janney Montgomery Scott first reported a position in BEAM in Q3 2021 and held it in 5 quarters. The position peaked at $690K in Q1 2022. 207 funds tracked by Wall St. Rank hold BEAM as of Q4 2022.

  • Janney Montgomery Scott reported no remaining Beam Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 8,308 Beam Therapeutics shares in Q4 2022, an estimated $396K.
  • Janney Montgomery Scott first reported a position in Beam Therapeutics in Q3 2021 and held it in 5 quarters.
  • Janney Montgomery Scott's Beam Therapeutics position peaked at $690K in Q1 2022.
  • 207 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2022.

Based on Janney Montgomery Scott's 13F filing for Q4 2022, filed 1 Feb 2023.